WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ROIV

Based on 6 analysts offering 12 month price targets for Roivant Sciences Ltd

Min Forecast
$30.00+5.08%
Avg Forecast
$34.00+19.09%
Max Forecast
$40.00+40.11%

Should I buy or sell ROIV stock?

Based on 6 analysts offering ratings for Roivant Sciences Ltd.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
2 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ROIV's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ROIV as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ROIV stock forecasts and price targets.

ROIV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-16Find Out Why
lockedlocked$00.00+00.00%2026-03-04
lockedlocked$00.00+00.00%2026-02-10Find Out Why
lockedlocked$00.00+00.00%2026-02-09
lockedlocked$00.00+00.00%2025-12-15
Goldman Sachs
Top 28%
73
Strong BuyMaintains$33.00+15.59%2025-12-15

1 of 1

Forecast return on equity

Is ROIV forecast to generate an efficient return?

Company
15.9%
Industry
85.46%
Market
175.5%
ROIV's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ROIV forecast to generate an efficient return on assets?

Company
12.99%
Industry
29.71%
ROIV is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ROIV earnings per share forecast

What is ROIV's earnings per share in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
-$1.34
Avg 2 year Forecast
-$1.27
Avg 3 year Forecast
$0.95

ROIV revenue forecast

What is ROIV's revenue in the next 3 years based on estimates from 14 analysts?

Avg 1 year Forecast
$77.5M+482.06%
Avg 2 year Forecast
$559.9M+4,106.54%
Avg 3 year Forecast
$1.7B+12,875.21%
ROIV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ROIV revenue growth forecast

How is ROIV forecast to perform vs Biotechnology companies and vs the US market?

Company
389.95%
Industry
33.49%
Market
14.23%
ROIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ROIV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ROIV vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ROIV$28.55$34.00+19.09%Strong Buy
BNTX$88.85$131.78+48.32%Strong Buy
MRNA$48.11$40.88-15.04%Hold
INCY$95.19$108.39+13.86%Buy
INSM$107.15$215.47+101.09%Strong Buy
View Top Biotech Stocks

Roivant Sciences Stock Forecast FAQ

Is Roivant Sciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: ROIV) stock is to Strong Buy ROIV stock.

Out of 6 analysts, 4 (66.67%) are recommending ROIV as a Strong Buy, 2 (33.33%) are recommending ROIV as a Buy, 0 (0%) are recommending ROIV as a Hold, 0 (0%) are recommending ROIV as a Sell, and 0 (0%) are recommending ROIV as a Strong Sell.

If you're new to stock investing, here's how to buy Roivant Sciences stock.

What is ROIV's earnings growth forecast for 2027-2029?

(NASDAQ: ROIV) Roivant Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.18%.

Roivant Sciences's earnings in 2026 is -$809,240,000.On average, 14 Wall Street analysts forecast ROIV's earnings for 2027 to be -$959,755,225, with the lowest ROIV earnings forecast at -$1,316,532,242, and the highest ROIV earnings forecast at -$511,010,612. On average, 12 Wall Street analysts forecast ROIV's earnings for 2028 to be -$907,652,182, with the lowest ROIV earnings forecast at -$1,332,635,517, and the highest ROIV earnings forecast at -$217,930,996.

In 2029, ROIV is forecast to generate $678,914,099 in earnings, with the lowest earnings forecast at $652,290,016 and the highest earnings forecast at $698,882,160.

What is ROIV's revenue growth forecast for 2027-2029?

(NASDAQ: ROIV) Roivant Sciences's forecast annual revenue growth rate of 389.95% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.49%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.23%.

Roivant Sciences's revenue in 2026 is $13,310,000.On average, 14 Wall Street analysts forecast ROIV's revenue for 2027 to be $55,446,798,486, with the lowest ROIV revenue forecast at $9,202,485,220, and the highest ROIV revenue forecast at $233,869,660,537. On average, 12 Wall Street analysts forecast ROIV's revenue for 2028 to be $400,713,909,595, with the lowest ROIV revenue forecast at $142,531,881,434, and the highest ROIV revenue forecast at $828,066,215,509.

In 2029, ROIV is forecast to generate $1,236,015,863,599 in revenue, with the lowest revenue forecast at $870,292,582,592 and the highest revenue forecast at $2,189,329,778,083.

What is ROIV's forecast return on assets (ROA) for 2027-2029?

(NASDAQ: ROIV) forecast ROA is 12.99%, which is lower than the forecast US Biotechnology industry average of 29.71%.

What is ROIV's Price Target?

According to 6 Wall Street analysts that have issued a 1 year ROIV price target, the average ROIV price target is $34.00, with the highest ROIV stock price forecast at $40.00 and the lowest ROIV stock price forecast at $30.00.

On average, Wall Street analysts predict that Roivant Sciences's share price could reach $34.00 by Apr 16, 2027. The average Roivant Sciences stock price prediction forecasts a potential upside of 19.09% from the current ROIV share price of $28.55.

What is ROIV's Earnings Per Share (EPS) forecast for 2027-2029?

(NASDAQ: ROIV) Roivant Sciences's current Earnings Per Share (EPS) is -$1.17. On average, analysts forecast that ROIV's EPS will be -$1.34 for 2027, with the lowest EPS forecast at -$1.84, and the highest EPS forecast at -$0.71. On average, analysts forecast that ROIV's EPS will be -$1.27 for 2028, with the lowest EPS forecast at -$1.86, and the highest EPS forecast at -$0.30. In 2029, ROIV's EPS is forecast to hit $0.95 (min: $0.91, max: $0.98).

What is ROIV's forecast return on equity (ROE) for 2027-2029?

(NASDAQ: ROIV) forecast ROE is 15.9%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.